BIS ETF

$12.70

Returns Overview

1 Month
-17.55%
3 Months
-22.12%
6 Months
-27.03%
YTD
-27.10%
1 Year
-60.03%
3 Years (annualized)
-28.66%
5 Years (annualized)
-16.25%
10 Years (annualized)
-26.36%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would BIS have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

Loading chart data...

3 Months Performance

Loading chart data...

6 Months Performance

Loading chart data...

1 Year Performance

Loading chart data...

Benchmark & Peers

Benchmark
NASDAQ Biotechnology Index(^NBI)
This ETF (YTD)
-27.10%
Peer Avg (YTD)
+12.13%
vs Peers
-39.23%

BIS ETF Performance

BIS performance across multiple time periods: 1-month -17.55%, YTD -27.10%, 1-year -60.03%, 3-year -28.66%, 5-year -16.25%, 10-year -26.36%.

BIS returns trail the peer average of 12.13% YTD. With an expense ratio of 0.95%, investors should weigh costs against performance when evaluating this ETF.

BIS performance comparison shows side-by-side returns with another fund. BIS alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-17.55%N/A
3 Months-22.12%N/A
6 Months-27.03%N/A
1 Year-60.03%N/A
3 Years-28.66%N/A
5 Years-16.25%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized